Lab Grown Diamond Market Outlook: 2026 to 2030

Capacity expanded faster than demand for six years, and price carried the adjustment. Growing capacity is the whole story of the decline. Wholesale lab grown fell roughly 74 percent between 2020 and 2025, per Edahn Golan Diamond Research. De Beers said lab grown wholesale jewelry prices fell about 90 percent and were tracking toward cost plus. A finished lab stone now costs 80 to 90 percent less than its mined equivalent, per BriteCo.

Cost plus is the language of a commodity at the bottom. It describes production cost, a thin margin, and nothing else. Once wholesale prices reach that line, further declines require a genuine reduction in the cost of growing, cutting, and certifying a stone. Those costs are physical. Reactor time, power, skilled cutting and independent grading all carry a real bill.

That is the boundary the market hit. The relevant question for 2026 to 2030 is no longer how far prices fall. It is what a market competes on once price stops moving.

Because they reached production cost, and cost does not fall on demand. StoneAlgo's May 2026 data shows a year over year decline of 2.59 percent and the smallest quarterly declines in two years. Set that against roughly 74 percent across six years and the shape of the market is obvious.

The endpoints make it concrete. A 1 carat lab diamond averaged 3,410 USD per carat in 2020. By May 2026 the 1 carat average was 564 USD. The decline that followed was not a discount cycle. It was a repricing to cost.

One consequence deserves emphasis. At May 2026 averages, moving from 1 carat at 564 USD to 3 carats at 1,865 USD costs a fraction of what a single carat cost in 2020. Through 2030, that arithmetic is the strongest force acting on what buyers actually choose. The narrower question of whether prices have further to fall is treated separately in the Draco 2026 price floor analysis, and the full historical series sits in the price trend report for 2020 to 2026.

It removes the industry's price setter from the lab grown category entirely. De Beers announced the closure of Lightbox on May 9, 2025. Lightbox had launched at 800 USD per carat, a number designed to frame lab grown as inexpensive fashion product rather than fine jewelry. That framing failed on both counts. Prices went below it, and buyers treated lab grown as fine jewelry anyway.

The parent company absorbed the cost. Anglo American wrote down De Beers by 6.8 billion USD over three years. De Beers posted a 511 million USD EBITDA loss in 2025. Anglo has targeted a sale or spinoff of De Beers in the first half of 2026. The full account sits in the Draco De Beers collapse report.

Three consequences follow, and each is a projection rather than a recorded fact. First, no single seller anchors lab grown pricing between 2026 and 2030, so published third party indices and independent certificates take on the anchoring role. Second, the natural diamond side loses the cross subsidy that a diversified giant provided, which is the bifurcation case argued in the Draco natural diamond bifurcation analysis. Third, buyer trust migrates toward whoever publishes verifiable data rather than whoever spends most on category advertising.

It confirmed that the low end of lab grown is a commodity and that the premium end needs a different label. On October 1, 2025, GIA stopped applying 4Cs nomenclature to lab grown diamonds and replaced it with premium and standard tiers. GIA stated that more than 95 percent of lab grown stones fall within one narrow color and clarity band.

Read that statistic carefully. If nearly all production lands in one band, then color and clarity stop sorting the market and something else has to. Two things do the sorting now. Cut quality, which is craft rather than chemistry. And the identity of the grading laboratory, since a report is only as strong as the institution behind it.

The practical effect for 2026 to 2030 is a widening gap between two products that share a name. Uncertified and lower grade material sits closest to raw production economics and may keep drifting lower. Independently certified premium stones sit at the cost floor. Buyers who cannot tell the two apart will overpay for the first and misprice the second. The comparison data is collected in the Draco lab grown versus natural statistics report.

Faster than the price data alone would suggest. On March 19, 2026, Signet Jewelers announced that the jamesallen.com website will be shut down and James Allen will become a proprietary collection inside Blue Nile. Signet said the domain goes dark during its second fiscal quarter, ending in early August 2026.

The numbers behind that decision are instructive. James Allen sales fell 33 percent to 142.5 million USD in the most recent fiscal year, a decline of nearly 49 percent over two years. Signet also said it expects the transition to reduce net revenue by 60 million to 80 million USD in fiscal 2027, and plans to close approximately 100 stores in the coming fiscal year. Rocksbox stops operating as a standalone brand and runs through Kay.

Two readings of that event matter for the outlook. A large multi brand retailer folding one of its best known online names into another is a supply side reaction to margin compression, not a signal about demand, which continues to grow. And with product abundant and priced at cost, retail scale by itself has stopped being a moat. What remains defensible is certification, published pricing, and how a company behaves after the sale.

Expect the competition to move from price to proof. The table below separates what is recorded from what is projected. Everything in the left column is sourced. Everything in the right column is an expectation, and no figure is attached to any of it, because no verified forward figure exists.

For a buyer, the practical read is short. Waiting has stopped paying at the certified end, because a 2.59 percent annual decline on a 564 USD average is a rounding error. Certification is the only reliable way to tell a premium stone from the 95 percent band. And size is the cheapest upgrade available at 2026 averages.

For a retailer, the read is equally short. Margin cannot be defended on access to stones, because stones are abundant. It can be defended on independent certification, published pricing, and terms that survive contact with a return request.

One boundary condition. A lab grown diamond is not an investment instrument. Lab grown typically recovers 20 to 40 percent of purchase price at resale, against 50 to 60 percent for natural, per 2026 market analyses. Nothing in this outlook argues for buying as a store of value.

Methodology note. Draco Diamond has tracked per carat lab diamond pricing since 2020 on IGI certified stones of E to F color and VS2 clarity and better, and records a decline of roughly 74 percent through 2026, corroborating Edahn Golan Diamond Research. Retail averages cited are StoneAlgo, May 2026, in USD. Corporate figures are as reported by Anglo American, De Beers Group and Signet Jewelers on the dates given. Projections are the author's, are identified as projections throughout, and carry no confidence interval.